GTS-21 reduced AngII-induced hypertension, improved baroreflex sensitivity and decreased fibrosis and inflammation. In vitro, GTS-21 suppressed NF-κB activation and reduced AngII-induced epithelial–mesenchymal transition, inflammation and fibrosis. This evidence concerns the gene AGT and hypertensive disorder.